A CENTRE OF EXCELLENCE
Connecting Patients, Policy and Practitioners
Oncothera Advocacy is a Registered Charity with the Australian Charities and Not–for–profit Commission.
ABOUT ONCOTHERA ADVOCACY
Collaboration is key
Oncothera Advocacy is at the forefront of driving collaboration in the fields of Oncology and Theranostics. Our team is dedicated to advancing the integration of diagnostic and therapeutic technologies to enhance patient outcomes. We are committed to making a meaningful impact in the healthcare landscape.
ONCOTHERA ADVOCACY'S VISION
Accessible treatments for patients
New treatments are urgently needed for cancer patients. Oncothera's vision is to enable all stakeholders for theranostic treatment to work together to provide accessible treatment for patients: to make more theranostic treatments more accessible to more patients.
​
We have proactively consulted widely with different stakeholders including specialists in various therapy areas, established a medical steering committee and finalised our strategic vision.
​
Oncothera Advocacy has established and is now focusing on three strategic pillars:
-
Partnerships & Collaboration
-
Industry Events & Education
-
Patient Organisations
Partnerships & Collaboration
Theranostics partnerships and collaborations involve interdisciplinary efforts between healthcare providers, researchers, pharmaceutical companies, and technology developers to advance the field's capabilities. By pooling expertise and resources, these collaborations aim to accelerate the development of innovative theranostic technologies, enhance patient care, and ultimately improve outcomes for individuals with various diseases.
Industry Events
Theranostics events and education initiatives provide valuable platforms for healthcare professionals and researchers to exchange knowledge, share best practices, and stay updated on the latest advancements in the field. Through conferences, workshops, and educational programs, these events foster collaboration, promote interdisciplinary learning, and contribute to the continuous improvement of theranostic techniques and applications.
Patient Organisations
Patient organisations play a crucial role in advocating for individuals affected by diseases that can benefit from theranostic approaches. By providing support, resources, and information, these organisations empower patients to make informed decisions about their healthcare and advocate for access to theranostic technologies and treatments.
Why Theranostics?
Theranostics holds immense importance in modern medicine due to its revolutionary approach to patient care. By combining diagnostic and therapeutic capabilities into a single platform, theranostics offers personalised treatment strategies tailored to individual patients' needs. This targeted approach allows for early detection of diseases, precise localisation of pathological tissues, and delivery of therapeutic agents directly to affected areas, minimising systemic side effects. Theranostics also enables real-time monitoring of treatment response, allowing clinicians to adjust therapy as needed for optimal outcomes.
With its potential to improve patient outcomes, reduce healthcare costs, and advance precision medicine, theranostics represents a significant paradigm shift in healthcare delivery and holds promise for addressing some of the most pressing challenges in disease management.
The Patient Journey
Theranostics has a profound impact on patients' lives by revolutionising the way diseases are diagnosed and treated. By providing personalised and precise medical interventions, theranostics offers patients the opportunity for early detection, targeted therapy, and improved treatment outcomes.
This approach reduces unnecessary treatments and minimises the risk of adverse side effects, enhancing the overall quality of life for patients. Moreover, theranostics enables clinicians to tailor treatment plans based on individual patient characteristics, preferences, and responses, fostering a sense of empowerment and involvement in their healthcare journey.
Ultimately, theranostics empowers patients to take control of their health and provides hope for a brighter future with more effective and personalised medical care.
White Paper
We are seeking expressions of interest for any individuals and organisations who would like to input to this White Paper.
​
This white paper explores the transformative potential of theranostics in modern medicine. By seamlessly integrating diagnostic and therapeutic capabilities, theranostics offers personalized treatment solutions tailored to individual patient needs. Through real-world case studies and emerging technologies, this paper highlights the significant impact of theranostics across various medical specialties. From early disease detection to targeted treatment delivery and patient monitoring, theranostics is reshaping the landscape of healthcare by improving outcomes, reducing side effects, and enhancing patient quality of life.
OUR COMMITTEE AND PARTNERS
Advocacy in collaboration
We're thrilled to announce the establishment of the steering committee for Oncothera Advocacy, marking a significant milestone in our commitment to patient advocacy and support. This dedicated team will play a pivotal role in shaping our advocacy initiatives and ensuring the voices of patients are heard loud and clear.
​
Oncothera Advocacy is teaming up with top industry partners to strengthen our mission of advocating for patients affected by cancer. Together, we're dedicated to advancing research, raising awareness, and improving access to innovative therapies.
-
Showoff Group (creative & design)
-
Lucid Health Consulting (health economics)
GET IN TOUCH
Let’s Collaborate
Reach out to us to explore opportunities for collaboration and learn more about our initiatives in advancing Theranostic treatment accessibility.
